Ingrid P. Buchler

Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)

John I. Trujillo, Marvin J. Meyers, David R. Anderson et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 137 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +11

Evidence for Separate Binding and Scaffolding Domains in the Immunosuppressive and Antitumor Marine Natural Product, Pateamine A:  Design, Synthesis, and Activity Studies Leading to a Potent Simplified Derivative

Daniel Romo, Nam Song Choi, Shukun Li et al. · Journal of the American Chemical Society · 2004 · 83 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Promyelinating drugs promote functional recovery in an autism spectrum disorder mouse model of Pitt–Hopkins syndrome

Joseph F. Bohlen, Colin Cleary, Debamitra Das et al. · Brain · 2023 · 36 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Aminopyrazole Carboxamide Bruton’s Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning

Mark E. Schnute, Stephen Benoit, Ingrid P. Buchler et al. · ACS Medicinal Chemistry Letters · 2018 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Development of a PC12 Cell Based Assay for Screening Catechol- <i>O</i> -methyltransferase Inhibitors

Gongliang Zhang, Ingrid P. Buchler, Michael DePasquale et al. · ACS Chemical Neuroscience · 2019 · 25 citations · Full text

Medicine, Pharmacology, Toxicology +12